The debate over whether to use animal or human cell lines in research goes beyond scientific performance—it touches ethics, reproducibility, and translational value. Two widely used animal-derived models, CHO cells (Chinese Hamster Ovary cells) and Vero cells (African green monkey kidney cells), illustrate the strengths and limitations of non-human lines compared to human-derived systems.
Ethical Considerations
Human cell lines typically require explicit consent and strict ethical oversight. Early examples, including the HeLa line, highlight historical challenges with consent and patient rights—issues modern science has since corrected.
Animal lines avoid these ethical limitations but introduce other concerns related to biodiversity, sourcing, and potential zoonotic contamination.
Practical Advantages
CHO cells are ideal for manufacturing biologics such as monoclonal antibodies and vaccines. Their adaptability, robustness, and regulatory acceptance make them staples in industrial biotechnology. Vero cells are widely used in virology, including vaccine development, viral propagation, and viral safety testing.
Both cell lines offer strong consistency and predictable growth patterns, which are vital for large-scale production.
Scientific Relevance
While animal cell lines are practical, human cell lines provide more accurate representations of human biology, especially for cancer, immunology, and metabolic disorders.
Researchers often use both—CHO or Vero lines for production, and human cancer lines for mechanistic studies.
Conclusion
Choosing between animal and human cell lines depends on the goals of the project. For biomanufacturing and virology, animal models like CHO and Vero excel. For disease modeling and therapeutic development, human lines offer superior translational value.
